A double robust approach to causal effects in case-control studies.

PubWeight™: 0.91‹?›

🔗 View Article (PMC 3939846)

Published in Am J Epidemiol on January 31, 2014

Authors

Sherri Rose, Mark van der Laan

Articles cited by this

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology (2000) 15.40

A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst (1951) 9.86

Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81

Super learner. Stat Appl Genet Mol Biol (2007) 5.73

A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62

Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat Med (2002) 4.15

Effects of body composition and leisure-time physical activity on transitions in physical functioning in the elderly. Am J Epidemiol (2005) 3.40

Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis (2007) 3.16

Hepatitis B in China. Lancet (2007) 2.67

Diagnosing and responding to violations in the positivity assumption. Stat Methods Med Res (2010) 2.29

Randomized recruitment in case-control studies. Am J Epidemiol (1991) 2.19

Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol (2007) 2.00

Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. Am J Epidemiol (2004) 1.94

A targeted maximum likelihood estimator of a causal effect on a bounded continuous outcome. Int J Biostat (2010) 1.89

Why match? Investigating matched case-control study designs with causal effect estimation. Int J Biostat (2009) 1.83

Estimation based on case-control designs with known prevalence probability. Int J Biostat (2008) 1.81

Effects of physical activity and body composition on functional limitation in the elderly: application of the marginal structural model. Epidemiology (2004) 1.71

An application of collaborative targeted maximum likelihood estimation in causal inference and genomics. Int J Biostat (2010) 1.48

Collaborative targeted maximum likelihood for time to event data. Int J Biostat (2010) 1.41

Simple optimal weighting of cases and controls in case-control studies. Int J Biostat (2008) 1.40

Association between self-reported leisure-time physical activity and measures of cardiorespiratory fitness in an elderly population. Am J Epidemiol (1998) 1.30

A weighting approach to causal effects and additive interaction in case-control studies: marginal structural linear odds models. Am J Epidemiol (2011) 1.26

Mortality risk score prediction in an elderly population using machine learning. Am J Epidemiol (2013) 1.22

Population intervention causal effects based on stochastic interventions. Biometrics (2011) 1.18

The relative performance of targeted maximum likelihood estimators. Int J Biostat (2011) 1.17

Hepatitis C seroprevalence and associated risk factors, Anyang, China. Emerg Infect Dis (2009) 1.07

Comparing approaches to causal inference for longitudinal data: inverse probability weighting versus propensity scores. Int J Biostat (2010) 0.97

A targeted maximum likelihood estimator for two-stage designs. Int J Biostat (2011) 0.87

Accounting for perception, placebo and unmasking effects in estimating treatment effects in randomised clinical trials. Stat Methods Med Res (2011) 0.83

Finding Quantitative Trait Loci Genes with Collaborative Targeted Maximum Likelihood Learning. Stat Probab Lett (2011) 0.81

Articles by these authors

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22

Effects of body composition and leisure-time physical activity on transitions in physical functioning in the elderly. Am J Epidemiol (2005) 3.40

Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. Am J Epidemiol (2011) 3.29

Changes in health care spending and quality 4 years into global payment. N Engl J Med (2014) 2.64

Leisure-time physical activity and all-cause mortality in an elderly cohort. Epidemiology (2009) 2.29

An application of model-fitting procedures for marginal structural models. Am J Epidemiol (2005) 2.14

A method to increase the power of multiple testing procedures through sample splitting. Stat Appl Genet Mol Biol (2006) 1.81

Identification of regulatory elements using a feature selection method. Bioinformatics (2002) 1.80

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One (2009) 1.72

A randomized, controlled trial of in-home drinking water intervention to reduce gastrointestinal illness. Am J Epidemiol (2005) 1.59

Cravings as a mediator and moderator of drinking outcomes in the COMBINE study. Addiction (2013) 1.59

Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates. Am J Epidemiol (2002) 1.48

Influenza vaccination and mortality: differentiating vaccine effects from bias. Am J Epidemiol (2009) 1.46

Modelling the network of cell cycle transcription factors in the yeast Saccharomyces cerevisiae. BMC Bioinformatics (2006) 1.41

Population intervention causal effects based on stochastic interventions. Biometrics (2011) 1.18

Analyzing Direct Effects in Randomized Trials with Secondary Interventions: An Application to HIV Prevention Trials. J R Stat Soc Ser A Stat Soc (2009) 1.03

Profiling Cys34 adducts of human serum albumin by fixed-step selected reaction monitoring. Mol Cell Proteomics (2010) 0.97

Exploratory and confirmatory gene expression profiling of mac1Delta. J Biol Chem (2003) 0.96

How well can post-traumatic stress disorder be predicted from pre-trauma risk factors? An exploratory study in the WHO World Mental Health Surveys. World Psychiatry (2014) 0.95

Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children. Environ Mol Mutagen (2011) 0.94

Improving propensity score estimators' robustness to model misspecification using super learner. Am J Epidemiol (2014) 0.90

partDSA: deletion/substitution/addition algorithm for partitioning the covariate space in prediction. Bioinformatics (2010) 0.89

Lung cancer survival with herbal medicine and vitamins in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods. Integr Cancer Ther (2011) 0.86

Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods. Integr Cancer Ther (2011) 0.83

Major depressive disorder subtypes to predict long-term course. Depress Anxiety (2014) 0.82

Finding Quantitative Trait Loci Genes with Collaborative Targeted Maximum Likelihood Learning. Stat Probab Lett (2011) 0.81

Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies. Am J Epidemiol (2016) 0.76

Discussion of Evaluation of Viable Dynamic Treatment Regimes in a Sequentially Randomized Trial of Advanced Prostate Cancer, by Wang et al. 2012. J Am Stat Assoc (2012) 0.75

Addressing missing data in clinical trials. Ann Intern Med (2011) 0.75

Rose and van der Laan respond to "Some advantages of the relative excess risk due to interaction". Am J Epidemiol (2014) 0.75

One-Step Targeted Minimum Loss-based Estimation Based on Universal Least Favorable One-Dimensional Submodels. Int J Biostat (2016) 0.75

Using Super Learner Prediction Modeling to Improve High-Dimensional Propensity Score Estimation. Epidemiology (2017) 0.75

Accounting for heterogeneous treatment effects in the FDA approval process. Food Drug Law J (2012) 0.75